Lonza in Gene-Therapy Manufacturing Pact
By

By
Lonza Houston, the viral gene and cell therapy-manufacturing unit of Lonza, has entered into a strategic manufacturing agreement with Selecta Biosciences, a Watertown, Masachusetts-based clinical-stage biopharmaceutical company, under which Lonza…

Quotient Acquires Charles River’s CDMO Unit
By

By
Quotient Clinical, a Nottingham, UK-based early phase drug development services provider, has acquired QS Pharma, Charles River Laboratories International’s contract development and manufacturing organization unit based near Philadelphia. Founded in…

Catalent Completes OTC Softgel Buy
By

By
Catalent has completed its previously announced acquisition of Accucaps Industries Limited, an Ontario, Canada-based developer and manufacturer of over-the-counter (OTC), high potency, and conventional pharmaceutical softgels. The company announced the…

FDA Accepts Mylan’s Filing for Neulasta Biosimilar
By

By
The US Food and Drug Administration (FDA) has accepted a biologics license application from Mylan and its partner, Biocon, a Bangalore, India-headquartered biopharmaceuticals company, for a proposed biosimilar to Amgen’s…

Takeda Completes $5.2-Billion Acquisition of Ariad
By

By
Takeda Pharmaceutical has completed its previously announced acquisition of Ariad Pharmaceuticals, headquartered in Cambridge, Massachusetts, for $24 per share in cash, or an enterprise value of approximately $5.2 billion. The…

QPSI Buys Prescription and OTC Packaging Company
By

By
Quality Packaging Specialists International (QPSI), a privately owned Burlington, New Jersey-headquartered outsourced packaging supply-chain solution provider, has acquired 100% ownership of International Labs, a St. Petersburg, Florida-headquartered prescription drug and…

Ferring Partners in Extended-Release Peptide Therapeutic
By

By
Ferring Pharmaceuticals, a Saint-Prex, Switzerland-headquartered specialty biopharmaceutical group, has entered into an exclusive worldwide development and option agreement with Foresee Pharmaceuticals, a Taipei City, Taiwan-headquartered clinical-stage pharmaceutical company to use…

Symbiosis Pharmaceutical Expands Sterile Filling Business
By

By
Symbiosis Pharmaceutical Services, a Stirling, Scotland-headquartered contract manufacturing organization, is opening a commercial office in Cambridge, Massachusetts to expand its sterile vial-filling services in North America. The office is intended…

Novasep to Build $29-Million Viral Vector Manufacturing Facility
By

By
Novasep, a Lyon, France-headquartered contract manufacturing organization, has invested EUR 27 million ($29 million) to build a commercial-scale manufacturing plant for viral vector-based therapeutics at the company’s site in Seneffe,…

Hikma Expands Solid-Dose Manufacturing Plant
By

By
West-Ward Pharmaceuticals, a Columbus, Ohio-based generic prescription medication provider and a wholly owned subsidiary of Hikma Pharmaceuticals, an Amman, Jordan-based pharmaceutical company, has announced an expansion at its solid-dosage facility…